Evidence map›Paper›PMID 25518023›Full record

ReviewClinics (Sao Paulo, Brazil)2014

Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy.

Patricia Azevedo de Lima, Leticia Pereira de Brito Sampaio, Nágila Raquel Teixeira Damasceno

Open access · goldAbstract readReview
In one paragraph

Review in Clinics (Sao Paulo, Brazil), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 94 citations in OpenAlex.

  1. Effects of a ketogenic diet on body composition and strength in trained women.Journal of the International Society of Sports Nutrition · 2020
    Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Research progress on correlations between trace element levels and epilepsy.Frontiers in cell and developmental biology · 2023
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. A Ketogenic & Low-Protein Diet Slows Retinal Degeneration in rd10 Mice.Translational vision science & technology · 2020
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Patricia Azevedo de LimaPost-Graduate Program in Applied Human Nutrition, Universidade de São Paulo, São Paulo, SP, Brazil.
Leticia Pereira de Brito SampaioChildren's Institute, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Nágila Raquel Teixeira DamascenoDepartment of Nutrition, School of Public Health, Universidade de São Paulo, São Paulo, SP, Brazil.
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A ketogenic diet is an important therapy used in the control of drug-refractory seizures. Many studies have shown that children and adolescents following ketogenic diets exhibit an over 50% reduction in seizure frequency, which is considered to be clinically relevant. These benefits are based on a diet containing high fat (approximately 90% fat) for 24 months. This dietary model was proposed in the 1920s and has produced variable clinical responses. Previous studies have shown that the mechanisms underlying seizure control involve ketone bodies, which are produced by fatty acid oxidation. Although the pathways involved in the ketogenic diet are not entirely clear, the main effects of the production of ketone bodies appear to be neurotransmitter modulation and antioxidant effects on the brain. This review highlights the impacts of the ketogenic diet on the modulation of neurotransmitters, levels of biogenic monoamines and protective antioxidant mechanisms of neurons. In addition, future perspectives are proposed.

Indexed as

AdolescentBiogenic MonoaminesChildDiet, KetogenicEpilepsyHumansKetone BodiesMedical IllustrationNeuroprotective AgentsNeurotransmitter AgentsBiogenic MonoaminesKetone BodiesNeuroprotective AgentsNeurotransmitter Agents

Identifiers

PMID25518023
PMCPMC4221309
OpenAlexW2065338532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.